D
Da-Qing Wu
Researcher at Cornell University
Publications - 16
Citations - 899
Da-Qing Wu is an academic researcher from Cornell University. The author has contributed to research in topics: Self-healing hydrogels & Lower critical solution temperature. The author has an hindex of 9, co-authored 16 publications receiving 857 citations.
Papers
More filters
Patent
Hydrogel forming system comprising PEG derivative precursor
Da-Qing Wu,Chih-Chang Chu +1 more
TL;DR: Variation in precursor ratio and mass of double bond functionalized polyhydric alcohol precursor and polyethylene glycol diacrylate precursor provide a wide range of release rates of drug or other biologically active agent from hydrogel formed therefrom as discussed by the authors.
Patent
Injectable microspheres from unsaturated functionalized polyhydric alcohol esters
Chih-Chang Chu,Da-Qing Wu +1 more
TL;DR: In this paper, injectable drug laden microspheres are obtained from unsaturated functionalized polyhydric alcohol ester of polyester by a method comprising dissolving the unweighted functionalized ester in a hydrophobic organic solvent, dissolving drug and/or biologically active agent in water, admixing the two solutions to form water-in-oil emulsion, forming an aqueous solution of stabilizer, and evaporation of the organic solvent.
Journal ArticleDOI
Multiple Amino Acid Biodegradable Poly Ester-Amide (PEA) Polymer Coating Significantly Reduces Inflammation Associated with Suture Implantation
Tatiana Boyko,Karina A. Hernandez,Rachel Campbell,Andrew L. Weinstein,Alice Harper,Da-Qing Wu,Chih-Chang Chu,Jason A. Spector +7 more
TL;DR: A novel [2-Arg-4]-[2-Phe-4] Poly Ester-Amide (Arg-P he-PEA) coating is developed, a biocompatible molecule shown previously to reduce the infl ammatory reaction to certain implanted devices.
Patent
Advantageous hydrogel composition
TL;DR: In this paper, a hydrogel containing cationic BSA is included in a vaccine to stimulate the immune system to increase the potency of the vaccine, and the vaccine was used to prevent pneumonia.
Patent
Method for delivering an active agent using a hydrogel composition
TL;DR: In this paper, a hydrogel containing cationic BSA is included in a vaccine to stimulate the immune system to increase the potency of the vaccine, and the vaccine was used to prevent pneumonia.